Eledon Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q2 2015 to Q2 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Eledon Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q2 2015 to Q2 2025.
  • Eledon Pharmaceuticals, Inc. Debt-to-equity for the quarter ending June 30, 2025 was 95.5 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2025 95.5 +344 Jun 30, 2025
Q1 2025 353 +1.11K Mar 31, 2025
Q4 2024 -622 -824 -409% Dec 31, 2024
Q3 2024 -212 -290 -370% Sep 30, 2024
Q2 2024 -249 -280 -904% Jun 30, 2024
Q1 2024 -761 -769 -9986% Mar 31, 2024
Q4 2023 201 +196 +3348% Dec 31, 2023
Q3 2023 78.5 +74.3 +1784% Sep 30, 2023
Q2 2023 30.9 +27.3 +748% Jun 30, 2023
Q1 2023 7.7 +4.14 +116% Mar 31, 2023
Q4 2022 5.84 +2.03 +53.3% Dec 31, 2022
Q3 2022 4.16 +0.49 +13.3% Sep 30, 2022
Q2 2022 3.65 -0.93 -20.3% Jun 30, 2022
Q1 2022 3.56 -1.79 -33.5% Mar 31, 2022
Q4 2021 3.81 -2.98 -43.9% Dec 31, 2021
Q3 2021 3.68 -16.9 -82.1% Sep 30, 2021
Q2 2021 4.58 -10.1 -68.7% Jun 30, 2021
Q1 2021 5.35 -9.43 -63.8% Mar 31, 2021
Q4 2020 6.79 -11.7 -63.3% Dec 31, 2020
Q3 2020 20.6 +1.83 +9.76% Sep 30, 2020
Q2 2020 14.7 -2.09 -12.5% Jun 30, 2020
Q1 2020 14.8 +0.6 +4.23% Mar 31, 2020
Q4 2019 18.5 +9.33 +102% Dec 31, 2019
Q3 2019 18.8 +11.4 +156% Sep 30, 2019
Q2 2019 16.8 +8.7 +108% Jun 30, 2019
Q1 2019 14.2 +4.08 +40.4% Mar 31, 2019
Q4 2018 9.17 -2.01 -18% Dec 31, 2018
Q3 2018 7.31 -11.5 -61.1% Sep 30, 2018
Q2 2018 8.05 -13.8 -63.2% Jun 30, 2018
Q1 2018 10.1 -13.1 -56.4% Mar 31, 2018
Q4 2017 11.2 -9.73 -46.5% Dec 31, 2017
Q3 2017 18.8 -3.08 -14.1% Sep 30, 2017
Q2 2017 21.8 +5.93 +37.3% Jun 30, 2017
Q1 2017 23.2 +12.2 +111% Mar 31, 2017
Q4 2016 20.9 +11.9 +132% Dec 31, 2016
Q3 2016 21.9 +16.1 +275% Sep 30, 2016
Q2 2016 15.9 +10.6 +201% Jun 30, 2016
Q1 2016 11 Mar 31, 2016
Q4 2015 9.01 Dec 31, 2015
Q3 2015 5.83 Sep 30, 2015
Q2 2015 5.29 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.